(Q44169556)

30 November 2017

title

Topiramate selectively decreases intracortical excitability in human motor cortex (English)

1 reference

30 November 2017

7

Wolfgang H Oertel

1 reference

30 November 2017

2

Frithjof Tergau

1 reference

30 November 2017

8

Felix Rosenow

1 reference

30 November 2017

5

Susanne Knake

1 reference

30 November 2017

3

Hajo M Hamer

1 reference

30 November 2017

Janine Reis

1

1 reference

30 November 2017

Hans-Helge Müller

series ordinal

4

1 reference

30 November 2017

Brita Fritsch

series ordinal

6

1 reference

30 November 2017

publication date

1 October 2002

1 reference

30 November 2017

1 reference

30 November 2017

volume

43

1 reference

30 November 2017

issue

10

1 reference

30 November 2017

page(s)

1149-1156

1 reference

Clinical significance of animal seizure models and mechanism of action studies of potential antiepileptic drugs

30 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.09902.X

A randomized, placebo-controlled study of topiramate in primary generalized tonic-clonic seizures. Topiramate YTC Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.09902.X

Frequency-dependent inhibition of neuronal activity by topiramate in rat hippocampal slices

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.09902.X

Topiramate attenuates voltage-gated sodium currents in rat cerebellar granule cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.09902.X

Topiramate enhances GABA-mediated chloride flux and GABA-evoked chloride currents in murine brain neurons and increases seizure threshold

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.09902.X

Cellular actions of topiramate: blockade of kainate-evoked inward currents in cultured hippocampal neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.09902.X

Topiramate increases cerebral GABA in healthy humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.09902.X

Modulation of cerebral GABA by topiramate, lamotrigine, and gabapentin in healthy adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.09902.X

Topiramate rapidly raises brain GABA in epilepsy patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.09902.X

Cortical excitability in patients after loading doses of lamotrigine: a study with magnetic brain stimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.09902.X

Interaction between intracortical inhibition and facilitation in human motor cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.09902.X

Continuous intrathecal baclofen infusions induced a marked increase of the transcranially evoked silent period in a patient with generalized dystonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.09902.X

Riluzole suppresses motor cortex facilitation in correlation to its plasma level. A study using transcranial magnetic stimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.09902.X

Dextromethorphan decreases the excitability of the human motor cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.09902.X

Corticocortical inhibition in human motor cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.09902.X

Magnetic brain stimulation with a double coil: the importance of coil orientation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.09902.X

Differential effects on motorcortical inhibition induced by blockade of GABA uptake in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.09902.X

Complete suppression of voluntary motor drive during the silent period after transcranial magnetic stimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.09902.X

The muscle silent period following transcranial magnetic cortical stimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.09902.X

New graphical method to measure silent periods evoked by transcranial magnetic stimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.09902.X

Topiramate: a new antiepileptic drug for refractory epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.09902.X

Plasma concentration of topiramate correlates with cerebrospinal fluid concentration

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.09902.X

Effects of antiepileptic drugs on motor cortex excitability in humans: a transcranial magnetic stimulation study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.09902.X

The effect of lorazepam on the motor cortical excitability in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.09902.X

Influence of the N-methyl-D-aspartate antagonist memantine on human motor cortex excitability

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.09902.X

Excitability of the human motor cortex is enhanced during REM sleep

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.09902.X

Effects of phenytoin on cortical excitability in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.09902.X

On the origin of the postexcitatory inhibition seen after transcranial magnetic brain stimulation in awake human subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.09902.X

Aggravation of generalized epilepsies

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.09902.X

Nonconvulsive status epilepticus in two patients receiving tiagabine treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.09902.X

Reproducibility of intracortical inhibition and facilitation using the paired-pulse paradigm

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.09902.X

Tiagabine-induced absence status in idiopathic generalized epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.09902.X

Topiramate: a potent anticonvulsant in the amygdala-kindled rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.09902.X

Topiramate in refractory epilepsy: a prospective observational study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.09902.X

Modulation of high-voltage-activated calcium channels in dentate granule cells by topiramate

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.09902.X

Topiramate: preclinical evaluation of structurally novel anticonvulsant.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.09902.X

Early and late intracortical inhibition in juvenile myoclonic epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.09902.X

Utility of the lethargic (lh/lh) mouse model of absence seizures in predicting the effects of lamotrigine, vigabatrin, tiagabine, gabapentin, and topiramate against human absence seizures

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.09902.X

Use of topiramate in childhood generalized seizure disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.09902.X

10.1046/J.1528-1157.2002.09902.X

21 January 2018

Identifiers

DOI

1 reference

30 November 2017

1 reference